Abstract
Original language | Spanish (Colombia) |
---|---|
Pages (from-to) | 1467-1476 |
Number of pages | 10 |
Journal | Current Opinion in Rheumatology |
DOIs | |
State | Published - 2018 |
Author Keywords
- Concept
Access to Document
Other files and links
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
Sex Hormones and Rheumatoid Factor : a Possible Link Between Reproductive Hormones Patterns and the Onset of Rheumatoid Arthritis Among Women in. / Aletaha, Daniel; Neogi, Tuhina; Silman, Alan J.; Funovits, Julia; Felson, David T.; Bingham, Clifton O.; Birnbaum, Neal S.; Burmester, Gerd R.; Bykerk, Vivian P.; Cohen, Marc D.; Combe, Bernard; Costenbader, Karen H.; Dougados, Maxime; Emery, Paul; Ferraccioli, Gianfranco; Hazes, Johanna M.W.; Hobbs, Kathryn; Huizinga, Tom W.J.; Kavanaugh, Arthur; Kay, Jonathan; Kvien, Tore K.; Laing, Timothy; Mease, Philip; Ménard, Henri A.; Moreland, Larry W.; Naden, Raymond L.; Pincus, Theodore; Smolen, Josef S.; Stanislawska-Biernat, Ewa; Symmons, Deborah; Tak, Paul P.; Upchurch, Katherine S.; Vencovský, Jiří; Wolfe, Frederick; Hawker, Gillian; Elshafie, Amir I.; Elkhalifa, Abdalla D.; Elbagir, Sahwa; Aledrissy, Mawahib I.E.; Elagib, Elnour M.; Nur, Musa A.M.; Weitoft, Tomas; Rönnelid, Johan; Bioscience, Tosoh; Quintero, Olga L.; Amador-Patarroyo, Manuel J.; Montoya-Ortiz, Gladys; Rojas-Villarraga, Adriana; Anaya, Juan Manuel; Shelly, Shahar; Boaz, Mona; Orbach, Hedi; Agarwal, Sandeep K.; Wheeler, Michael J; Lashkari, Mahin; Noori, Akram; Oveisi, Sonia; Kheirkhah, Mohammadreza; Diseases, Metabolic; Health, Child; Diseases, Metabolic; Diseases, Metabolic; Engdahl, Cecilia; Bondt, Albert; Harre, Ulrike; Raufer, Jasmin; Pfeifle, René; Camponeschi, Alessandro; Wuhrer, Manfred; Seeling, Michaela; Mårtensson, Inga Lill; Nimmerjahn, Falk; Krönke, Gerhard; Scherer, Hans U.; Forsblad-d'Elia, Helena; Schett, Georg; Pierdominici, Marina; Maselli, Angela; Colasanti, Tania; Giammarioli, Anna Maria; Delunardo, Federica; Vacirca, Davide; Sanchez, Massimo; Giovannetti, Antonello; Malorni, Walter; Ortona, Elena; Provost, Meredith; Eaton, Jennifer L.; Clowse, Megan E.B.; Brouwer, Jenny; Hazes, Johanna M.W.; Laven, Joop S.E.; Dolhain, Radboud J.E.M.; de Jong, Pascal H.P.; Dolhain, Radboud J.E.M.
In: Current Opinion in Rheumatology, 2018, p. 1467-1476.Research output: Contribution to journal › Article › peer-review
TY - JOUR
T1 - Sex Hormones and Rheumatoid Factor : a Possible Link Between Reproductive Hormones Patterns and the Onset of Rheumatoid Arthritis Among Women in
AU - Aletaha, Daniel
AU - Neogi, Tuhina
AU - Silman, Alan J.
AU - Funovits, Julia
AU - Felson, David T.
AU - Bingham, Clifton O.
AU - Birnbaum, Neal S.
AU - Burmester, Gerd R.
AU - Bykerk, Vivian P.
AU - Cohen, Marc D.
AU - Combe, Bernard
AU - Costenbader, Karen H.
AU - Dougados, Maxime
AU - Emery, Paul
AU - Ferraccioli, Gianfranco
AU - Hazes, Johanna M.W.
AU - Hobbs, Kathryn
AU - Huizinga, Tom W.J.
AU - Kavanaugh, Arthur
AU - Kay, Jonathan
AU - Kvien, Tore K.
AU - Laing, Timothy
AU - Mease, Philip
AU - Ménard, Henri A.
AU - Moreland, Larry W.
AU - Naden, Raymond L.
AU - Pincus, Theodore
AU - Smolen, Josef S.
AU - Stanislawska-Biernat, Ewa
AU - Symmons, Deborah
AU - Tak, Paul P.
AU - Upchurch, Katherine S.
AU - Vencovský, Jiří
AU - Wolfe, Frederick
AU - Hawker, Gillian
AU - Elshafie, Amir I.
AU - Elkhalifa, Abdalla D.
AU - Elbagir, Sahwa
AU - Aledrissy, Mawahib I.E.
AU - Elagib, Elnour M.
AU - Nur, Musa A.M.
AU - Weitoft, Tomas
AU - Rönnelid, Johan
AU - Bioscience, Tosoh
AU - Quintero, Olga L.
AU - Amador-Patarroyo, Manuel J.
AU - Montoya-Ortiz, Gladys
AU - Rojas-Villarraga, Adriana
AU - Anaya, Juan Manuel
AU - Shelly, Shahar
AU - Boaz, Mona
AU - Orbach, Hedi
AU - Agarwal, Sandeep K.
AU - Wheeler, Michael J
AU - Lashkari, Mahin
AU - Noori, Akram
AU - Oveisi, Sonia
AU - Kheirkhah, Mohammadreza
AU - Diseases, Metabolic
AU - Health, Child
AU - Diseases, Metabolic
AU - Diseases, Metabolic
AU - Engdahl, Cecilia
AU - Bondt, Albert
AU - Harre, Ulrike
AU - Raufer, Jasmin
AU - Pfeifle, René
AU - Camponeschi, Alessandro
AU - Wuhrer, Manfred
AU - Seeling, Michaela
AU - Mårtensson, Inga Lill
AU - Nimmerjahn, Falk
AU - Krönke, Gerhard
AU - Scherer, Hans U.
AU - Forsblad-d'Elia, Helena
AU - Schett, Georg
AU - Pierdominici, Marina
AU - Maselli, Angela
AU - Colasanti, Tania
AU - Giammarioli, Anna Maria
AU - Delunardo, Federica
AU - Vacirca, Davide
AU - Sanchez, Massimo
AU - Giovannetti, Antonello
AU - Malorni, Walter
AU - Ortona, Elena
AU - Provost, Meredith
AU - Eaton, Jennifer L.
AU - Clowse, Megan E.B.
AU - Brouwer, Jenny
AU - Hazes, Johanna M.W.
AU - Laven, Joop S.E.
AU - Dolhain, Radboud J.E.M.
AU - de Jong, Pascal H.P.
AU - Dolhain, Radboud J.E.M.
PY - 2018
Y1 - 2018
N2 - Many rheumatic diseases affect women of childbearing age, and the medications used to treat these diseases may affect conception, pregnancy, fetal development, and lactation. Physicians who care for these women need to be aware of the potential adverse effects of these medications, and which medications can be used safely prior to conception and during pregnancy and lactation. Although reviews of individual classes of medications are available, there is no practical and comprehensive review that summarizes all of this information, and includes anticoagulant drugs and 2 recently approved drugs for rheumatoid arthritis. Women who take cytotoxic drugs should be informed of the risks of impaired fertility and congenital malformations, and must use effective methods of contraception. During pregnancy, nonsteroidal anti-inflammatory agents may be used until the last 6 weeks, and low to moderate doses of corticosteroids are safe throughout pregnancy. Among the disease-modifying agents, sulfasalazine and hydroxychloroquine treatment may be maintained. Cytotoxic drugs may be used after the first trimester to treat life-threatening disease. During lactation, prednisone, sulfasalazine, and hydroxychloroquine may be used cautiously. Women using heparin for treatment of antiphospholipid antibody syndrome should take measures to prevent bone loss. Men taking methotrexate, sulfasalazine, cyclosporine, azathioprine, or leflunomide should be apprised of the possibilities of infertility and teratogenicity.
AB - Many rheumatic diseases affect women of childbearing age, and the medications used to treat these diseases may affect conception, pregnancy, fetal development, and lactation. Physicians who care for these women need to be aware of the potential adverse effects of these medications, and which medications can be used safely prior to conception and during pregnancy and lactation. Although reviews of individual classes of medications are available, there is no practical and comprehensive review that summarizes all of this information, and includes anticoagulant drugs and 2 recently approved drugs for rheumatoid arthritis. Women who take cytotoxic drugs should be informed of the risks of impaired fertility and congenital malformations, and must use effective methods of contraception. During pregnancy, nonsteroidal anti-inflammatory agents may be used until the last 6 weeks, and low to moderate doses of corticosteroids are safe throughout pregnancy. Among the disease-modifying agents, sulfasalazine and hydroxychloroquine treatment may be maintained. Cytotoxic drugs may be used after the first trimester to treat life-threatening disease. During lactation, prednisone, sulfasalazine, and hydroxychloroquine may be used cautiously. Women using heparin for treatment of antiphospholipid antibody syndrome should take measures to prevent bone loss. Men taking methotrexate, sulfasalazine, cyclosporine, azathioprine, or leflunomide should be apprised of the possibilities of infertility and teratogenicity.
UR - https://www.mendeley.com/catalogue/b93e7f32-c45f-3573-81b8-9deaf4b279ed/
U2 - 10.1016/j.jaut.2009.11.015%0Ahttp://www.ncbi.nlm.nih.gov/pubmed/31507122%0Ahttp://dx.doi.org/10.1016/j.cellimm.2015.02.004%0Ahttp://biostor.org/reference/128533%0Ahttp://dx.doi.org/10.1038/nrrheum.2014.144%0Ahttps://doi.org/10.1007/s4074
DO - 10.1016/j.jaut.2009.11.015%0Ahttp://www.ncbi.nlm.nih.gov/pubmed/31507122%0Ahttp://dx.doi.org/10.1016/j.cellimm.2015.02.004%0Ahttp://biostor.org/reference/128533%0Ahttp://dx.doi.org/10.1038/nrrheum.2014.144%0Ahttps://doi.org/10.1007/s4074
M3 - Artículo
C2 - 10724046
SP - 1467
EP - 1476
JO - Current Opinion in Rheumatology
JF - Current Opinion in Rheumatology
SN - 1040-8711
ER -